STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. II. CHEMOTHERAPY OF VIRUS-INDUCED LYMPHOID LEUKEMIA.
D000818:Animals; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D003520:Cyclophosphamide; D005472:Fluorouracil; D007938:Leukemia; D007942:Leukemia, Experimental; D007945:Leukemia, Lymphoid; D008558:Melphalan; D015122:Mercaptopurine; D051379:Mice; D009858:Oncogenic Viruses; D010336:Pathology; D010600:Pharmacology; D011925:Rauscher Virus; D012106:Research; D013163:Splenomegaly; D013882:Thiosemicarbazones; D014750:Vincristine
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D013882:Thiosemicarbazones; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D008558:Melphalan; D005472:Fluorouracil
ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CYCLOPHOSPHAMIDE; EXPERIMENTAL LAB STUDY; FLUOROURACIL; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, LYMPHOCYTIC; MELPHALAN; MERCAPTOPURINE; MICE; ONCOGENIC VIRUSES; PATHOLOGY; PHARMACOLOGY; SPLENOMEGALY; THIOSEMICARBAZONES; VINCRISTINE